American Journal of Clinical Dermatology

, Volume 10, Issue 2, pp 73–86

Clinical Implications of Aging Skin

Cutaneous Disorders in the Elderly
  • Miranda A. Farage
  • Kenneth W. Miller
  • Enzo Berardesca
  • Howard I. Maibach
Review Article


Aging skin undergoes progressive degenerative change. Structural and physiologic changes that occur as a natural consequence of intrinsic aging combined with the effects of a lifetime of ongoing cumulative extrinsic damage and environment insult (e.g. overexposure to solar radiation) can produce a marked susceptibility to dermatologic disorders in the elderly. As skin ages, the vasculature progressively atrophies. The supporting dermis also deteriorates, with collagen and elastin fibers becoming sparse and increasingly disordered. These changes leave the elderly increasingly susceptible to both vascular disorders such as stasis dermatitis and skin injuries such as pressure ulcers and skin tears, with a steadily decreasing ability to effect skin repair.

A parallel erosion of normal immune function produces higher levels of autoimmune skin disorders such as bullous pemphigoid, benign mucous membrane pemphigoid, paraneoplastic pemphigoid, and pemphigus vulgaris. Lichen sclerosus, an autoimmune disorder often occurring in the genital area in older women, is not common but is an important development because of the potential for substantial discomfort as well as serious complications. The prevalence of polypharmacy in this population increases the risk for autoimmune drug reactions, and diagnosis should be undertaken with an awareness that polypharmacy in this population creates a greatly increased susceptibility to drug eruptions that can mimic other cutaneous disorders.

Immunologic senescence in the elderly also sets the stage for potential reactivation of the Varicella zoster virus, in which initial dermatologic involvement expands into the major sensory ganglia. Known as shingles, this disorder can be excruciatingly painful with the potential to cause blindness if the optic nerve becomes involved.

Dermatoses such as xerosis, pruritus, and eczema are also widespread in the elderly, create substantial suffering in those afflicted, and often prove recalcitrant to treatment. Individual susceptibility to specific types of contact dermatitis changes over the lifetime, and seborrheic dermatitis is substantially more prevalent in the elderly.

It is not uncommon for older patients to have multiple impairments, with the potential for cognitive dysfunction as well as impaired vision, hearing, or mobility. In addition, they may not have adequate housing or nutrition, or the financial resources necessary for adequate compliance. Physicians must take into consideration the patient’s physical ability to comply with the recommended therapy as well as socioeconomic factors that may impact on compliance. Simple topical regimens are preferable wherever possible in order to maximize compliance and, therefore, efficacy. Extra effort may be necessary to ensure that instructions are accurately followed and that ongoing compliance with the regimen prescribed is actually achieved.

Management of dermatologic disorders in the elderly is often less than optimal, due to the fact that the special needs and limitations of this population are not adequately considered. Treatments should consider the intrinsic differences between younger and older patients thatmay impact on diagnosis and therapy choice. The aged patient is often afflicted with numerous co-morbidities that can influence the choice of therapy. Skin integrity in the elderly is compromised, and safety concerns are increased with the long-term use of any medication prescribed. In addition, the prevalence of polypharmacy in the aged population substantially increases the risk of cutaneous drug reactions, which can profoundly complicate accurate diagnosis of dermatologic disorders. The aged population also needs to be more closely monitored because of increased fragility of the skin and the physical limitations that may hinder compliance with prescribed regimens.


  1. 1.
    Yannas I. Tissue and organ regeneration in adults. New York: Springer-Verlag, 2001Google Scholar
  2. 2.
    Monteiro-Riviere NA. Introduction to histological aspects of dermatotoxicology. Microsc Res Tech 1997; 37 (3): 171PubMedGoogle Scholar
  3. 3.
    Farage MA, Miller KW, Elsner P, et al. Structural characteristics of the aging skin: a review. Cutan Ocul Toxicol 2007; 26 (4): 343–57PubMedGoogle Scholar
  4. 4.
    Beauregard S, Gilchrest BA. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol 1987; 123 (12): 1638–43PubMedGoogle Scholar
  5. 5.
    Liao YH, Chen KH, Tseng MP, et al. Pattern of skin diseases in a geriatric patient group in Taiwan: a 7-year survey from the outpatient clinic of a university medical center. Dermatology 2001; 203 (4): 308–13PubMedGoogle Scholar
  6. 6.
    Gilchrest BA. Geriatric skin problems. Hosp Pract (Off Ed) 1986; 21 (9A): 55, 59-65Google Scholar
  7. 7.
    Baranoski S. Skin tears: the enemy of frail skin. Adv Skin Wound Care 2000; 13 (3 Pt 1): 123–6PubMedGoogle Scholar
  8. 8.
    Haroun MT. Dry skin in the elderly. Geriatr Aging 2003; 6 (6): 41–4Google Scholar
  9. 9.
    Fletcher K. Skin: geriatric self-learning module. Med surg Nurs 2005; 14 (2): 138–42Google Scholar
  10. 10.
    Boss GR, Seegmiller JE. Age-related physiological changes and their clinical significance. West J Med 1981; 135 (6): 434–40PubMedGoogle Scholar
  11. 11.
    Thaipisuttikul Y. Pruritic skin diseases in the elderly. J Dermatol 1998; 25: 153–7PubMedGoogle Scholar
  12. 12.
    Gilchrest BA, Chiu N. Common skin disorders [online]. Available from URL: [Accessed 2007 Jul 1]Google Scholar
  13. 13.
    Farage MA, Miller KW, Berardesca E, et al. Neoplastic skin lesions in the elderly patient. Cutan Ocul Toxicol 2008; 27: 1–7Google Scholar
  14. 14.
    Waller JM, Maibach HI. Age and skin structure and function, a quantitative approach (i): blood flow, ph, thickness, and ultrasound echogenicity. Skin Res Technol 2005; 11 (4): 221–35PubMedGoogle Scholar
  15. 15.
    Edlich RF, Winters KL, Woodard CR, et al. Pressure ulcer prevention. J Long Term Eff Med Implants 2004; 14 (4): 285–304PubMedGoogle Scholar
  16. 16.
    Wolff K, Johnson R, Suurmond R. Fitzpatrick’s color atlas and synopsis of clinical dermatology. 5th ed. New York: McGraw-Hill Professional, 2005Google Scholar
  17. 17.
    Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician 2000 Apr; 61 (8): 2437–44, 2447-8PubMedGoogle Scholar
  18. 18.
    Tierney L, McPhee S, Papadakis M. Current medical diagnosis and treatment. New York: McGraw Hill, 2000Google Scholar
  19. 19.
    Sollecito TP, Parisi E. Mucous membrane pemphigoid. Dent Clin North Am 2005; 49 (1): 91–106, viiiPubMedGoogle Scholar
  20. 20.
    Bickle K, Roark TR, Hsu S. Autoimmune bullous dermatoses: a review. Am Fam Physician 2002; 65 (9): 1861–70PubMedGoogle Scholar
  21. 21.
    Grove GL. Physiologic changes in older skin. Clin Geriatr Med 1989; 5 (1): 115–25PubMedGoogle Scholar
  22. 22.
    Harvell JD, Maibach HI. Percutaneous absorption and inflammation in aged skin: a review. J Am Acad Dermatol 1994; 31 (6): 1015–21PubMedGoogle Scholar
  23. 23.
    Brincat MP, Baron YM, Galea R. Estrogens and the skin. Climacteric 2005; 8 (2): 110–23PubMedGoogle Scholar
  24. 24.
    Martini F. Fundamentals of anatomy and physiology. San Francisco (CA): Benjamin-Cummings, 2004Google Scholar
  25. 25.
    Ghadially R. Aging and the epidermal permeability barrier: implications for contact dermatitis. Am J Contact Dermat 1998; 9 (3): 162–9PubMedGoogle Scholar
  26. 26.
    Spencer SK, Kierland RR. The aging skin: problems and their causes. Geriatrics 1970; 25 (4): 81–9PubMedGoogle Scholar
  27. 27.
    White JV, Ryjewski C. Chronic venous insufficiency. Perspect Vasc Surg Endovasc Ther 2005; 17 (4): 319–27PubMedGoogle Scholar
  28. 28.
    Shai A, Maibach HI. Wound healing and ulcers of the skin: diagnosis and therapy–the practical approach. New York: Springer, 2005Google Scholar
  29. 29.
    Trent JT, Falabella A, Eaglstein WH, et al. Venous ulcers: pathophysiology and treatment options. Ostomy Wound Manage 2005; 51 (5): 38–54, quiz 55-; quiz 56PubMedGoogle Scholar
  30. 30.
    Carter DM, Balin AK. Dermatological aspects of aging. Med Clin North Am 1983; 67 (2): 531–43PubMedGoogle Scholar
  31. 31.
    Fitzpatrick JE. Common inflammatory skin diseases of the elderly. Geriatrics 1989; 44 (7): 40–6PubMedGoogle Scholar
  32. 32.
    Coleridge Smith PD. Deleterious effects of white cells in the course of skin damage in CVI. Int Angiol 2002; 21 (2 Suppl. 1): 26–32PubMedGoogle Scholar
  33. 33.
    Leu AJ, Leu HJ, Franzeck UK, et al. Microvascular changes in chronic venous insufficiency: a review. Cardiovasc Surg 1995; 3 (3): 237–45PubMedGoogle Scholar
  34. 34.
    Webster GF. Common skin disorders in the elderly. Clin Cornerstone 2001; 4 (1): 39–44PubMedGoogle Scholar
  35. 35.
    Quatresooz P, Henry F, Paquet P, et al. Deciphering the impaired cytokine cascades in chronic leg ulcers (review). Int J Mol Med 2003; 11 (4): 411–8PubMedGoogle Scholar
  36. 36.
    Buckley C, Rustin MH. Management of irritable skin disorders in the elderly. Br J Hosp Med 1990; 44 (1): 24–6, 28, 30-2PubMedGoogle Scholar
  37. 37.
    Herouy Y, Nockowski P, Schöpf E, et al. Lipodermatosclerosis and the significance of proteolytic remodeling in the pathogenesis of venous ulceration (review). Int J Mol Med 1999; 3 (5): 511–5PubMedGoogle Scholar
  38. 38.
    Smoker A. Skin care in old age. Nurs Stand 1999; 13 (48): 47–53PubMedGoogle Scholar
  39. 39.
    Gilchrest B, Krutmann J, editors. Skin aging. New York: Springer, 2006Google Scholar
  40. 40.
    Brem H, Tomic-Canic M, Tarnovskaya A, et al. Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers. Surg Technol Int 2003; 11 (1): 161–7PubMedGoogle Scholar
  41. 41.
    Johnson S. Compression hosiery in the prevention and treatment of venous leg ulcers. J Tissue Viability 2002 Apr; 12 (2): 67, 70, 72-4PubMedGoogle Scholar
  42. 42.
    Machet L, Couhé C, Perrinaud A, et al. A high prevalence of sensitization still persists in leg ulcer patients: a retrospective series of 106 patients tested between 2001 and 2002 and a meta-analysis of 1975–2003 data. Br J Dermatol 2004; 150 (5): 929–35PubMedGoogle Scholar
  43. 43.
    Berlowitz DR, Wilking SVB. Pressure ulcers in the nursing home. In: Reubentein L, Wieland D, editors. Improving care in the nursing home: comprehensive reviews of clinical research. Newbury Park (CA): Sage Publications, 1993Google Scholar
  44. 44.
    The National Pressure Ulcer Advisory Panel. Pressure ulcers prevalence, cost, and risk assessment: consensus development conference statement. Decubitus 1989; 2 (2): 24–8Google Scholar
  45. 45.
    Remsburg RE, Bennett RG. Pressure-relieving strategies for preventing and treating pressure sores. Clin Geriatr Med 1997; 13 (3): 513–41PubMedGoogle Scholar
  46. 46.
    Nola GT, Vistnes LM. Differential response of skin and muscle in the experimental production of pressure sores. Plast Reconstr Surg 1980; 66 (5): 728–33PubMedGoogle Scholar
  47. 47.
    Baeke JL. Hospital-acquired pressure ulcers: an epidemic. Plast Reconstr Surg 2000; 106 (4): 945–6PubMedGoogle Scholar
  48. 48.
    Mathus-Vliegen EMH. Old age, malnutrition, and pressure sores: an ill-fated alliance. J Gerontol A Biol Sci Med Sci 2004; 59 (4): 355–60PubMedGoogle Scholar
  49. 49.
    Stratton RJ, Ek A, Engfer M, et al. Enteral nutritional support in prevention and treatment of pressure ulcers: a systematic review and meta-analysis. Ageing Res Rev 2005; 4 (3): 422–50PubMedGoogle Scholar
  50. 50.
    Kleinsmith DM, Perricone NV. Common skin problems in the elderly. Dermatol Clin 1986; 4 (3): 485–99PubMedGoogle Scholar
  51. 51.
    Cohen AF, Tiemstra JD. Diagnosis and treatment of rosacea. J Am Board Fam Pract 2002; 15 (3): 214–7PubMedGoogle Scholar
  52. 52.
    Diaz C, O’Callaghan CJ, Khan A, et al. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study. Acta Derm Venereol 2003; 83 (4): 282–6PubMedGoogle Scholar
  53. 53.
    Boixeda de Miquel D, Vázquez Romero M, Vázquez Sequeiros E, et al. Effect of Helicobacter pylori eradication therapy in rosacea patients. Rev Esp Enferm Dig 2006; 98 (7): 501–9PubMedGoogle Scholar
  54. 54.
    Baldwin HE. Systemic therapy for rosacea. Skin Therapy Lett 2007; 12 (2): 1–5, 9PubMedGoogle Scholar
  55. 55.
    Loo WJ, Burrows NP. Management of autoimmune skin disorders in the elderly. Drugs Aging 2004; 21 (12): 767–77PubMedGoogle Scholar
  56. 56.
    Walsh SRA, Hogg D, Mydlarski PR. Bullous pemphigoid: from bench to bedside. Drugs 2005; 65 (7): 905–26PubMedGoogle Scholar
  57. 57.
    American Academy of Dermatology. Bullous disease [online]. Available from URL: [Accessed 2007 Nov 7]
  58. 58.
    Shelley WB, Shelley ED. The ten major problems of aging skin. Geriatrics 1982; 37 (9): 107–13PubMedGoogle Scholar
  59. 59.
    Mutasim DF. Autoimmune bullous dermatoses in the elderly: diagnosis and management. Drugs Aging 2003; 20 (9): 663–81PubMedGoogle Scholar
  60. 60.
    Laforest C, Huilgol SC, Casson R, et al. Autoimmune bullous diseases: ocular manifestations and management. Drugs 2005; 65 (13): 1767–79PubMedGoogle Scholar
  61. 61.
    Tehranchi-Nia Z, Qureshi TA, Ahmed AR. Pemphigus vulgaris in older adults. J Am Geriatr Soc 1998; 46 (1): 92–4PubMedGoogle Scholar
  62. 62.
    Farage MA, Maibach HI, editors. The vulva: anatomy, physiology, and pathology. New York: Informa Healthcare, 2006Google Scholar
  63. 63.
    Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol 2002; 147 (4): 640–9PubMedGoogle Scholar
  64. 64.
    Lorenz B, Kaufman RH, Kutzner SK. Lichen sclerosus: therapy with clobetasol propionate. J Reprod Med 1998; 43 (9): 790–4PubMedGoogle Scholar
  65. 65.
    Bleiker TO, Graham-Brown RA. Diagnosing skin disease in the elderly. Practitioner 2000; 244 (1616): 974–81PubMedGoogle Scholar
  66. 66.
    Niv D, Maltsman-Tseikhin A, Lang E. Postherpetic neuralgia: what do we know and where are we heading? Pain Physician 2004; 7 (2): 239–47PubMedGoogle Scholar
  67. 67.
    Johnson R. Herpes zoster: predicting and minimizing the impact of postherpetic neuralgia. J Antimicrob Chemother 2001; 47 Suppl. T1: 1–8PubMedGoogle Scholar
  68. 68.
    Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352 (22): 2271–84PubMedGoogle Scholar
  69. 69.
    Koplan JP, Harpaz R. Shingles vaccine: effective and costly or cost-effective? Ann Intern Med 2006; 145 (5): 386–7PubMedGoogle Scholar
  70. 70.
    Norman RA. Xerosis and pruritus in elderly patients, part 1. Ostomy Wound Manage 2006; 52: 2–4Google Scholar
  71. 71.
    Peters S. Dermatologic issues in the elderly: examining common problems. Adv Nurse Pract 1999; 7: 63–4Google Scholar
  72. 72.
    Shwayder T. Ichthyosis in a nutshell. Pediatr Rev 1999; 20: 5–12PubMedGoogle Scholar
  73. 73.
    Resnick B. Dermatologic problems in the elderly. Lippincotts Prim Care Pract 1997; 1: 14–30, quiz 31-2PubMedGoogle Scholar
  74. 74.
    Harding CR, Watkinson A, Rawlings AV, et al. Dry skin, moisturization and corneodesmolysis. Int J Cosmet Sci 2000; 22: 21–52PubMedGoogle Scholar
  75. 75.
    Rawlings AV, Leyden JL. Skin moisturization. New York: Marcel Dekker, 2002Google Scholar
  76. 76.
    Loden M, Maibach H, editors. Dry skin and moisturizers: chemistry and function. Boca Raton (FL): CRC Press, 2006Google Scholar
  77. 77.
    Jennings MB, Alfieri D, Ward K, et al. Comparison of salicylic acid and urea versus ammonium lactate for the treatment of foot xerosis: a randomized, double-blind, clinical study. J Am Podiatr Med Assoc 1998; 88: 332–6PubMedGoogle Scholar
  78. 78.
    Fleischer ABJ. Pruritus in the elderly. Adv Dermatol 1995; 10: 41–60PubMedGoogle Scholar
  79. 79.
    Waisman M. A clinical look at the aging skin. Postgrad Med 1979; 66: 87–93, 96PubMedGoogle Scholar
  80. 80.
    Yosipovitch G. Assessment of itch: more to be learned and improvements to be made. J Invest Dermatol 2003; 121: xiv–xvPubMedGoogle Scholar
  81. 81.
    Perkins P. The management of eczema in adults (continuing education credit). Nurs Stand 1996; 10: 49–53; quiz 55-6PubMedGoogle Scholar
  82. 82.
    Braun M, Lowitt MH. Pruritus. Adv Dermatol 2001; 17: 1–27PubMedGoogle Scholar
  83. 83.
    Fleischer ABJ. Pruritus in the elderly: management by senior dermatologists. J Am Acad Dermatol 1993; 28: 603–9PubMedGoogle Scholar
  84. 84.
    Long CC, Marks R. Stratum corneum changes in patients with senile pruritus. J Am Acad Dermatol 1992; 27: 560–4PubMedGoogle Scholar
  85. 85.
    Beare JM. Generalized pruritus: a study of 43 cases. Clin Exp Dermatol 1976 Dec; 1 (4): 343–52PubMedGoogle Scholar
  86. 86.
    Lim SPR, Abdullah A. Managing skin disease in elderly patients. Practitioner 2004; 248 (1655): 100–4, 106, 108-9PubMedGoogle Scholar
  87. 87.
    Gupta MA, Gupta AK. Medically unexplained cutaneous sensory symptoms may represent somatoform dissociation: an empirical study. J Psychosom Res 2006; 60: 131–6PubMedGoogle Scholar
  88. 88.
    DeWitt S. Nursing assessment of the skin and dermatologic lesions. Nurs Clin North Am 1990; 25: 235–45Google Scholar
  89. 89.
    Rogers C. Lichen simplex chronicus. Dermatol Nurs 2003; 15: 271PubMedGoogle Scholar
  90. 90.
    du Vivier A. Atlas of clinical dermatology. London: Churchill Livingstone, 2002Google Scholar
  91. 91.
    Soter NA. Nummular eczematous dermatitis. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 1999Google Scholar
  92. 92.
    Piaserico S, Larese F, Recchia GP, et al. Allergic contact sensitivity in elderly patients. Aging Clin Exp Res 2004; 16: 221–5PubMedGoogle Scholar
  93. 93.
    Ghadially R, Brown BE, Sequeira-Martin SM, et al. The aged epidermal permeability barrier: structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest 1995; 95: 2281–90PubMedGoogle Scholar
  94. 94.
    Nedorost ST, Stevens SR. Diagnosis and treatment of allergic skin disorders in the elderly. Drugs Aging 2001; 18 (11): 827–35PubMedGoogle Scholar
  95. 95.
    Tavadia S, Bianchi J, Dawe RS, et al. Allergic contact dermatitis in venous leg ulcer patients. Contact Dermatitis 2003; 48: 261–5PubMedGoogle Scholar
  96. 96.
    Chew AL, Maibach HI, editors. Irritant dermatitis. Berlin/Heidleberg: Springer, 2005Google Scholar
  97. 97.
    Levin C, Zhai H, Bashir S, et al. Efficacy of corticosteroids in acute experimental irritant contact dermatitis? Skin Res Technol 2001; 7: 214–8PubMedGoogle Scholar
  98. 98.
    Levin C, Zhai H, Maibach H. Corticosteroids of clinical value in lipid-soluble chemical-induced irritation in man?. Exog Dermatol 2002; 1: 97–101Google Scholar
  99. 99.
    Sandström Falk MH, Tengvall Linder M, Johansson C, et al. The prevalence of Malassezia yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls. Acta Derm Venereol 2005; 85: 17–23PubMedGoogle Scholar
  100. 100.
    Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician 2006; 74: 125–30PubMedGoogle Scholar
  101. 101.
    Schwartz JR, Cardin CW, Dawson TLJ. Dandruff and seborrheic dermatitis. In: Baran R, Maibach HI, editors. Textbook of cosmetic dermatology. London: Martin Dunitz, Ltd., 2004: 259–71Google Scholar
  102. 102.
    Mastrolonardo M, Diaferio A, Logroscino G. Seborrheic dermatitis, increased sebum excretion, and Parkinson’s disease: a survey of (im)possible links. Med Hypotheses 2003; 60: 907–11PubMedGoogle Scholar
  103. 103.
    Laube S, Farrell AM. Bacterial skin infections in the elderly: diagnosis and treatment. Drugs Aging 2002; 19 (5): 331–42PubMedGoogle Scholar
  104. 104.
    Kauppinen K, Alanko K, Hannuksela M. Skin reactions to drugs. Boca Raton (FL): CRC Press, 1998Google Scholar
  105. 105.
    Kooken AR, Tomecki KJ. The Cleveland Clinic Disease Management Project: drug eruptions [online]. Available from URL: [Accessed 2007 May 10]Google Scholar
  106. 106.
    Blume JE, Helm TN, Ehrlich M, et al. emedicine from WebMD: drug eruptions [online]. Available from URL: [Accessed 2007 May 10]Google Scholar
  107. 107.
    Bachot N, Roujeau J. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003; 4 (8): 561–72PubMedGoogle Scholar
  108. 108.
    Sullivan JR, Shear NH. Drug eruptions and other adverse drug effects in aged skin. Clin Geriatr Med 2002; 18 (1): 21–42PubMedGoogle Scholar
  109. 109.
    Drug eruptions. In: Fry L. An atlas of dermatology. New York: Parthenon Publishing Group, 1997Google Scholar
  110. 110.
    Kligman AM, Koblenzer C. Demographics and psychological implications for the aging population. Dermatol Clin 1997; 15 (4): 549–53PubMedGoogle Scholar
  111. 111.
    Klaassen C, editor. Casarett and Doull’s toxicology: the basic science of poisons. New York: McGraw-Hill, 1996Google Scholar
  112. 112.
    Kurban RS, Kurban AK. Common skin disorders of aging: diagnosis and treatment. Geriatrics 1993; 48 (4): 30–1, 35-6, 39-42PubMedGoogle Scholar

Copyright information

© Adis Data Information BV 2009

Authors and Affiliations

  • Miranda A. Farage
    • 1
  • Kenneth W. Miller
    • 1
  • Enzo Berardesca
    • 2
  • Howard I. Maibach
    • 3
  1. 1.The Procter & Gamble Company, Winton Hill Business CenterCincinnatiUSA
  2. 2.San Gallicano Dermatological InstituteRomeItaly
  3. 3.Department of DermatologyUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations